Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Doc Stone's Bierstube und Trading Room -- Ignore unavailable to you. Want to Upgrade?

To: M. Frank Greiffenstein who wrote (508)	2/4/1999 11:08:00 AM
From: wolfdog2	Respond to of 638

Doc, I have no idea if a speculative buy is better than an outright buy in Fahnestock's jargon. It was the content of the report that I thought people might find interesting. Crinone contains generic progesterone. It's delivery system is patented, however, and Crinone has been approved by the FDA for two indications. Progesterone is used in infertility, as well as hormone replacement therapy and dysmenorrhea. Crinone is currently approved by the FDA for the first and last indication. A P3 trial for HRT will be undertaken after the new marketing arrangements for Crinone are set in motion.

To: M. Frank Greiffenstein who wrote (508)	2/4/1999 11:23:00 AM
From: Joe Copia	Respond to of 638

MCFR could gap up tomorrow am : techstocks.com Joe PTG&LI !!!